Omenuko, N., Ugwu, C., Patel, K., Ubah, N. (2025). Comparative 3- and 5-year outcomes among first-line imatinib, dasatinib, and nilotinib in chronic myeloid leukemia: A real world analysis. Blood. https://doi.org/10.1182/blood-2025-7288